Display options
Share it on

Alzheimers Dement (Amst). 2016 Apr 08;4:6-13. doi: 10.1016/j.dadm.2016.03.006. eCollection 2016.

Expanding the phenotypic associations of globular glial tau subtypes.

Alzheimer's & dementia (Amsterdam, Netherlands)

James R Burrell, Shelley Forrest, Thomas H Bak, John R Hodges, Glenda M Halliday, Jillian J Kril

Affiliations

  1. Neuroscience Research Australia, Sydney, Australia; University of New South Wales, Sydney, Australia.
  2. Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia.
  3. Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, United Kingdom.

PMID: 27489873 PMCID: PMC4949736 DOI: 10.1016/j.dadm.2016.03.006

Abstract

INTRODUCTION: Clinicopathologic correlation in non-Alzheimer's tauopathies is variable, despite refinement of pathologic diagnostic criteria. In the present study, the clinical and neuroimaging characteristics of globular glial tauopathy (GGT) were examined to determine whether subtyping according to consensus guidelines improves clinicopathologic correlation.

METHODS: Confirmed GGT cases (n = 11) were identified from 181 frontotemporal tauopathy cases. Clinical and neuroimaging details were collected, and cases sub-typed according to the consensus criteria for GGT diagnosis. Relationships between clinical syndrome and GGT subtype were investigated.

RESULTS: In total, 11 patients (seven males, four females, mean age = 67.3 +/- 10.6 years) with GGT were included. Most, but not all, presented with behavioral variant frontotemporal dementia, but none had amyotrophic lateral sclerosis. Subtyping of GGT proved to be difficult and did not improve clinicopathologic correlation.

DISCUSSION: Sub-classification of GGT pathology may be difficult and did not improve clinicopathologic correlation. Better biomarkers of tau pathology are needed.

Keywords: Clinicopathological correlation; Frontotemporal dementia; Globular glial tau; Tauopathy

References

  1. Cogn Behav Neurol. 2015 Jun;28(2):92-7 - PubMed
  2. J Alzheimers Dis. 2015 ;44(2):705-20 - PubMed
  3. J Neuropathol Exp Neurol. 2008 Oct;67(10):963-75 - PubMed
  4. Cortex. 2015 Aug;69:220-36 - PubMed
  5. Brain. 2011 Sep;134(Pt 9):2478-92 - PubMed
  6. J Neuropathol Exp Neurol. 2001 Apr;60(4):328-41 - PubMed
  7. Science. 2015 Jul 31;349(6247):464 - PubMed
  8. Alzheimers Dement. 2016 Feb;12(2):110-20 - PubMed
  9. Lancet Neurol. 2014 Jun;13(6):614-29 - PubMed
  10. Acta Neuropathol. 2010 Jul;120(1):21-32 - PubMed
  11. Dement Geriatr Cogn Disord. 2010;30(1):1-7 - PubMed
  12. Acta Neuropathol. 2007 Jul;114(1):5-22 - PubMed
  13. Neurochem Int. 2001 Nov-Dec;39(5-6):469-79 - PubMed
  14. Acta Neuropathol. 2011 Oct;122(4):415-28 - PubMed
  15. Curr Neurol Neurosci Rep. 2014 Nov;14 (11):500 - PubMed
  16. Eur Neurol. 1998 Aug;40(2):71-7 - PubMed
  17. Brain. 2013 Nov;136(Pt 11):3474-88 - PubMed
  18. Acta Neuropathol. 2015 Aug;130(2):199-214 - PubMed
  19. Lancet Neurol. 2015 Jan;14 (1):114-24 - PubMed
  20. Acta Neuropathol. 2013 Oct;126(4):537-44 - PubMed
  21. Acta Neuropathol. 2003 Nov;106(5):419-35 - PubMed
  22. Curr Opin Neurobiol. 2016 Feb;36:43-51 - PubMed
  23. Neurology. 2006 Jan 10;66(1):41-8 - PubMed
  24. Neuron. 2013 Sep 18;79(6):1094-108 - PubMed
  25. Lancet Neurol. 2015 Mar;14(3):253-62 - PubMed
  26. Ann Neurol. 2015 Nov;78(5):787-800 - PubMed
  27. Neuropathol Appl Neurobiol. 2008 Aug;34(4):468-72 - PubMed
  28. Nature. 2015 Jul 30;523(7562):509-10 - PubMed
  29. Lancet Neurol. 2012 Oct;11(10):839-41 - PubMed
  30. Neuropathol Appl Neurobiol. 2015 Feb;41(1):3-23 - PubMed
  31. Acta Neuropathol. 2005 Dec;110(6):600-9 - PubMed
  32. Cell Rep. 2014 Jun 26;7(6):2054-65 - PubMed
  33. Acta Neuropathol. 2003 Aug;106(2):181-7 - PubMed
  34. N Engl J Med. 2012 Aug 30;367(9):795-804 - PubMed
  35. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):865-70 - PubMed
  36. Brain. 2010 Jul;133(Pt 7):2045-57 - PubMed
  37. J Neuropathol Exp Neurol. 2006 Apr;65(4):396-405 - PubMed

Publication Types

Grant support